Author

Sreyashi Nath

Observed name: S. Nath

Institutions: Homi Bhabha National Institute, Tata Memorial Hospital, Advanced Centre for Treatment, Research and Education in Cancer

Observed institutions: Homi Bhabha National Institute, Tata Memorial Hospital, Advanced Centre for Treatment, Research and Education in Cancer

ORCID: 0000-0002-5615-3570

Observed ORCID: 0000-0002-5615-3570

OpenAlex ID: A5004865467

Synthesis and Antidiabetic Evaluation of Benzothiazole Derivatives

2012 · G. Mariappan, P. Prabhat, et al. · Journal of the Korean Chemical Society · 78

Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication

2024 · Swarnali Das, Sreyashi Nath, et al. · DARU Journal of Pharmaceutical Sciences · 3

A kinetically inert platinum antitumor agent overcomes mutant p53-driven chemoresistance via oxidative stress-mediated DNA damage

2026 · Sourav Chakraborty, Priti S. Shenoy, et al. · Medical Oncology

Abstract 3101: Identification and characterization of novel peptide binders against platinum resistant epithelial ovarian cancer

2026 · Pritha Ray, Sreyashi Nath, et al. · Cancer Research

Works count: 4

Citation count: 81

H-index: 2

I10-index: 1